JP2020513849A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020513849A5 JP2020513849A5 JP2019571194A JP2019571194A JP2020513849A5 JP 2020513849 A5 JP2020513849 A5 JP 2020513849A5 JP 2019571194 A JP2019571194 A JP 2019571194A JP 2019571194 A JP2019571194 A JP 2019571194A JP 2020513849 A5 JP2020513849 A5 JP 2020513849A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- fragment
- composition according
- nucleic acid
- mast4
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022159928A JP7498239B2 (ja) | 2017-03-08 | 2022-10-04 | Ｍａｓｔ４遺伝子を利用した細胞外基質生産用組成物及びその製造方法 |
| JP2024087859A JP2024116197A (ja) | 2017-03-08 | 2024-05-30 | Ｍａｓｔ４遺伝子を利用した細胞外基質生産用組成物及びその製造方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2017-0029607 | 2017-03-08 | ||
| KR20170029607 | 2017-03-08 | ||
| KR10-2018-0027111 | 2018-03-07 | ||
| KR1020180027111A KR102588627B1 (ko) | 2017-03-08 | 2018-03-07 | Mast4 유전자를 이용한 세포외 기질 생산용 조성물 및 그 제조방법 |
| PCT/KR2018/002763 WO2018164507A2 (ko) | 2017-03-08 | 2018-03-08 | Mast4 유전자를 이용한 세포외 기질 생산용 조성물 및 그 제조방법 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022159928A Division JP7498239B2 (ja) | 2017-03-08 | 2022-10-04 | Ｍａｓｔ４遺伝子を利用した細胞外基質生産用組成物及びその製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020513849A JP2020513849A (ja) | 2020-05-21 |
| JP2020513849A5 true JP2020513849A5 (enExample) | 2021-04-15 |
| JP7154238B2 JP7154238B2 (ja) | 2022-10-17 |
Family
ID=63718648
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571194A Active JP7154238B2 (ja) | 2017-03-08 | 2018-03-08 | Ｍａｓｔ４遺伝子を利用した細胞外基質生産用組成物及びその製造方法 |
| JP2022159928A Active JP7498239B2 (ja) | 2017-03-08 | 2022-10-04 | Ｍａｓｔ４遺伝子を利用した細胞外基質生産用組成物及びその製造方法 |
| JP2024087859A Pending JP2024116197A (ja) | 2017-03-08 | 2024-05-30 | Ｍａｓｔ４遺伝子を利用した細胞外基質生産用組成物及びその製造方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022159928A Active JP7498239B2 (ja) | 2017-03-08 | 2022-10-04 | Ｍａｓｔ４遺伝子を利用した細胞外基質生産用組成物及びその製造方法 |
| JP2024087859A Pending JP2024116197A (ja) | 2017-03-08 | 2024-05-30 | Ｍａｓｔ４遺伝子を利用した細胞外基質生産用組成物及びその製造方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11180573B2 (enExample) |
| EP (1) | EP3594324A4 (enExample) |
| JP (3) | JP7154238B2 (enExample) |
| KR (1) | KR102588627B1 (enExample) |
| CN (1) | CN110612348B (enExample) |
| AU (2) | AU2018231559A1 (enExample) |
| CA (1) | CA3055729A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021146566A1 (en) * | 2020-01-16 | 2021-07-22 | The Johns Hopkins University | Engineered fibroblasts as cell therapy to treat cancer via tumor stroma stabilization |
| WO2022020785A2 (en) * | 2020-07-23 | 2022-01-27 | Orthobio Therapeutics, Inc. | Gene editing to improve joint function |
| AU2023215206A1 (en) * | 2022-02-04 | 2024-08-22 | Pyunggang Kim | Method of making bone and cartilage |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5055298A (en) * | 1987-12-01 | 1991-10-08 | Chemisches Laboratorium Dr. Kurt Richter Gmbh | Cosmetic composition comprising an extracellular connective tissue matrix |
| US6528052B1 (en) | 2000-09-29 | 2003-03-04 | The Board Of Trustees Of The Leland Stanford Junior University | Method for in vivo ex vivo and in vitro repair and regeneration of cartilage and collagen and bone remodeling |
| WO2005121316A1 (en) * | 2004-06-11 | 2005-12-22 | Bernard O'brien Institute Of Microsurgery | Tissue material and muscle derived matrix |
| KR100614903B1 (ko) * | 2004-08-06 | 2006-08-25 | 테고사이언스 (주) | 케라티노사이트 및/또는 섬유아세포를 함유하는 화장용조성물 |
| EP1894581A1 (en) | 2006-08-31 | 2008-03-05 | CellCoTec B.V. | Repair of cartilage tissue using a matrix gel containing chondrocytes |
| JP2011526585A (ja) * | 2008-03-31 | 2011-10-13 | スカルセル テラピュティク | 皮膚の老化の美容的処置法 |
| MX353186B (es) | 2009-09-03 | 2018-01-05 | Genentech Inc | Metodos para el tratamiento, diagnosis y monitoreo de artritis reumatoide. |
| WO2012083363A1 (en) * | 2010-12-22 | 2012-06-28 | Murdoch Childrens Research Institute | A method of treatment |
| ES2727334T3 (es) * | 2011-09-07 | 2019-10-15 | 3 D Matrix Ltd | Métodos y ensayos basados en microARN para el osteosarcoma |
| US9878056B2 (en) | 2012-04-02 | 2018-01-30 | Modernatx, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
| KR102039311B1 (ko) | 2012-09-07 | 2019-11-04 | 주식회사 마크로젠 | Ａｘｌ을 포함하는 융합 단백질 및 이를 포함하는 암 진단용 조성물 |
| WO2015035395A1 (en) | 2013-09-09 | 2015-03-12 | Figene, Llc | Gene therapy for the regeneration of chondrocytes or cartilage type cells |
| CN105916979A (zh) * | 2013-11-14 | 2016-08-31 | 德玛奇实验室公司 | 成纤维细胞混合物及其制备和使用方法 |
| CA2986441A1 (en) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| AU2017207445B2 (en) | 2016-01-14 | 2023-12-07 | Spinalcyte, Llc | Cellular blend for the regeneration of chondrocytes or cartilage type cells |
-
2018
- 2018-03-07 KR KR1020180027111A patent/KR102588627B1/ko active Active
- 2018-03-08 EP EP18764604.7A patent/EP3594324A4/en active Pending
- 2018-03-08 JP JP2019571194A patent/JP7154238B2/ja active Active
- 2018-03-08 AU AU2018231559A patent/AU2018231559A1/en not_active Abandoned
- 2018-03-08 CN CN201880030519.0A patent/CN110612348B/zh active Active
- 2018-03-08 US US16/492,477 patent/US11180573B2/en active Active
- 2018-03-08 CA CA3055729A patent/CA3055729A1/en active Pending
-
2021
- 2021-10-05 US US17/494,765 patent/US20220220221A1/en not_active Abandoned
-
2022
- 2022-10-04 JP JP2022159928A patent/JP7498239B2/ja active Active
-
2023
- 2023-08-31 AU AU2023222944A patent/AU2023222944A1/en active Pending
-
2024
- 2024-05-30 JP JP2024087859A patent/JP2024116197A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2872304C (en) | Organic compositions to treat kras-related diseases | |
| JP6158833B2 (ja) | ベータ−カテニン関連疾患を処置するための有機組成物 | |
| JP2020513849A5 (enExample) | ||
| CN112996913B (zh) | 寡聚核酸分子及其应用 | |
| CN113249380A (zh) | 靶向covid-19新冠病毒的反义寡核苷酸、natac嵌合分子及其应用 | |
| JP2022188178A (ja) | Ｍａｓｔ４遺伝子を利用した細胞外基質生産用組成物及びその製造方法 | |
| CN105861551A (zh) | 联合表达microRNAs抑制乳腺癌细胞增殖的载体及其构建方法和应用 | |
| Mustfa et al. | Porous Silicon Nanoneedles Efficiently Deliver Adenine Base Editor to Correct a Recurrent Pathogenic COL7A1 Variant in Recessive Dystrophic Epidermolysis Bullosa | |
| US20110152203A1 (en) | Transfection agent | |
| US20220290157A1 (en) | Compositions and methods for treating amyotrophic lateral sclerosis | |
| US20230265426A1 (en) | Combinatorial inhibition of mirnas for treatment of heart failure | |
| CN101590243A (zh) | 微小rna在制备治疗和/或预防淋巴瘤药物中的应用 | |
| WO2019037133A1 (zh) | 靶向沉默APP的shRNA | |
| US20250009805A1 (en) | Olfactory extracellular vesicles and uses thereof | |
| CN115916975A (zh) | 靶向mitf基因的核酸分子及其用途 | |
| WO2022018266A1 (en) | Combinatorial inhibition of transcription factors for treatment of heart failure | |
| HK40048024B (en) | Oligomeric nucleic acid molecule and application thereof | |
| HK40048024A (en) | Oligomeric nucleic acid molecule and application thereof | |
| CN117959344A (zh) | 一种诱导双靶点再平衡的方法和组合物 | |
| JP6687948B2 (ja) | 遺伝子発現制御のための発現抑制核酸分子およびその用途 | |
| JP2023031025A (ja) | 小胞分泌制御剤および小胞取り込み制御剤 | |
| Le et al. | Identification and characterization of MIR-3085 in chondrocytes | |
| IT201900018509A1 (it) | Aptameri e loro usi | |
| CN110358769A (zh) | 经锁核酸和硫代磷酸修饰的miRNA类似物及其在制备抗肿瘤药物中的应用 | |
| NZ623459B2 (en) | Micrornas in neurodegenerative disorders |